About Polaris Partners
Polaris Partners is a venture capital firm operating three specialized investment platforms: a core venture fund focused on healthcare and life sciences, the Polaris Growth Fund targeting profitable, founder-owned business-to-business SaaS companies, and the Polaris Innovation Fund dedicated to translating early-stage academic biomedical research into viable companies. The firm invests across business-to-business, business-to-consumer, healthcare information technology, software as a service, life sciences, health technology, and digital health sectors, committing $10 million to $50 million per investment, with the Growth Fund specifically targeting companies generating $4 million to $20 million in annual revenue. Transaction types span seed, Series A, Series B, and growth-stage equity financings, with the firm generally taking minority ownership positions while allowing founders to retain significant control, particularly within its growth fund structure. Polaris applies an active, hands-on partnership approach informed by nearly three decades of company-building experience, having backed more than 400 companies and helped bring more than 50 therapies to market, with notable portfolio companies including Akamai Technologies, Datadog, Trulia, and BarkBox. The firm has raised more than $5 billion in committed capital across 22 funds since inception and maintains a cross-Atlantic and Asia-Pacific presence through an affiliate office in Singapore. Founded in 1996 by Jonathan Flint, Terry McGuire, and Steve Arnold, the firm is headquartered in Boston, Massachusetts, United States, with additional offices in New York, New York, and San Francisco, California.